RXO Inc. price target raised to $32 from $30 at Barclays

Barclays raised the firm’s price target on RXO Inc. to $32 from $30 and keeps an Overweight rating on the shares post the Q2 report. RXO’s Q3 volume guidance likely weighed on the share price, but coming into 2025 the stock should trade on the company’s ability to leverage a freight market recovery and integrate Coyote, the analyst tells investors in a research note.